These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33555114)

  • 1. One-year results of the first-in-man study investigating the Atrial Flow Regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE study.
    Paitazoglou C; Bergmann MW; Özdemir R; Pfister R; Bartunek J; Kilic T; Lauten A; Schmeisser A; Zoghi M; Anker SD; Sievert H; Mahfoud F;
    Eur J Heart Fail; 2021 May; 23(5):800-810. PubMed ID: 33555114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction.
    Paitazoglou C; Özdemir R; Pfister R; Bergmann MW; Bartunek J; Kilic T; Lauten A; Schmeisser A; Zoghi M; Anker S; Sievert H; Mahfoud F
    EuroIntervention; 2019 Aug; 15(5):403-410. PubMed ID: 31130524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
    Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M;
    J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interatrial Shunting for Heart Failure: Early and Late Results From the First-in-Human Experience With the V-Wave System.
    Rodés-Cabau J; Bernier M; Amat-Santos IJ; Ben Gal T; Nombela-Franco L; García Del Blanco B; Kerner A; Bergeron S; Del Trigo M; Pibarot P; Shkurovich S; Eigler N; Abraham WT
    JACC Cardiovasc Interv; 2018 Nov; 11(22):2300-2310. PubMed ID: 30391390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicted impact of atrial flow regulator on survival in heart failure with reduced and preserved ejection fraction.
    Lauder L; Bergmann MW; Paitazoglou C; Özdemir R; Iliadis C; Bartunek J; Lauten A; Keller T; Weber S; Sievert H; Anker SD; Mahfoud F
    ESC Heart Fail; 2023 Aug; 10(4):2559-2566. PubMed ID: 37312287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.
    Hasenfuß G; Hayward C; Burkhoff D; Silvestry FE; McKenzie S; Gustafsson F; Malek F; Van der Heyden J; Lang I; Petrie MC; Cleland JG; Leon M; Kaye DM;
    Lancet; 2016 Mar; 387(10025):1298-304. PubMed ID: 27025436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
    Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
    Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.
    Shah SJ; Feldman T; Ricciardi MJ; Kahwash R; Lilly S; Litwin S; Nielsen CD; van der Harst P; Hoendermis E; Penicka M; Bartunek J; Fail PS; Kaye DM; Walton A; Petrie MC; Walker N; Basuray A; Yakubov S; Hummel SL; Chetcuti S; Forde-McLean R; Herrmann HC; Burkhoff D; Massaro JM; Cleland JGF; Mauri L
    JAMA Cardiol; 2018 Oct; 3(10):968-977. PubMed ID: 30167646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No-Implant Interatrial Shunt for HFpEF: 6-Month Outcomes From Multicenter Pilot Feasibility Studies.
    Udelson JE; Barker CM; Wilkins G; Wilkins B; Gooley R; Lockwood S; Potter BJ; Meduri CU; Fail PS; Solet DJ; Feldt K; Kriegel JM; Shaburishvili T
    JACC Heart Fail; 2023 Aug; 11(8 Pt 2):1121-1130. PubMed ID: 37115132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study.
    Del Trigo M; Bergeron S; Bernier M; Amat-Santos IJ; Puri R; Campelo-Parada F; Altisent OA; Regueiro A; Eigler N; Rozenfeld E; Pibarot P; Abraham WT; Rodés-Cabau J
    Lancet; 2016 Mar; 387(10025):1290-7. PubMed ID: 27025435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left atrial to coronary sinus shunting for treatment of heart failure with mildly reduced or preserved ejection fraction: The ALT FLOW Early Feasibility Study 1-year results.
    Urey MA; Hibbert B; Jorde U; Eckman P; Simard T; Labinaz M; Nazer B; Wiley M; Gupta B; Sauer A; Shah H; Sorajja P; Pineda AM; Missov E; Mahmud E; Kahwash R; Lilly S; Latib A; Murthy S; Fam N; Garcia S; Chung ES; Klein L; Cheng R; Houston BA; Amoroso NS; Chang L; Gafoor S; Chaudhry SP; Hermiller J; Schwartz JG; Aldaia L; Koulogiannis K; Gray WA; Zahr F
    Eur J Heart Fail; 2024 Apr; 26(4):1065-1077. PubMed ID: 38606485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Atrial to Coronary Sinus Shunting for Treatment of Symptomatic Heart Failure.
    Hibbert B; Zahr F; Simard T; Labinaz M; Nazer B; Sorajja P; Eckman P; Pineda AM; Missov E; Mahmud E; Schwartz J; Gupta B; Wiley M; Sauer A; Jorde U; Latib A; Kahwash R; Lilly S; Chang L; Gafoor S; Chaudhry SP; Hermiller J; Aldaia L; Koulogiannis K; Gray WA;
    JACC Cardiovasc Interv; 2023 Jun; 16(11):1369-1380. PubMed ID: 36989271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of atrial flow regulator implantation on hemodynamic parameters in patients with heart failure.
    Bakhshaliyev N; Ozdemir R
    Kardiologiia; 2021 Oct; 61(10):71-80. PubMed ID: 34763641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of atrial flow regulator (AFR) implantation on 12-month mortality in heart failure : Insights from a single site in the PRELIEVE study.
    Bakhshaliyev N; Çelikkale İ; Enhoş A; Karaçöp E; Uluganyan M; Özdemir R
    Herz; 2022 Aug; 47(4):366-373. PubMed ID: 34459929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.
    Shah SJ; Borlaug BA; Chung ES; Cutlip DE; Debonnaire P; Fail PS; Gao Q; Hasenfuß G; Kahwash R; Kaye DM; Litwin SE; Lurz P; Massaro JM; Mohan RC; Ricciardi MJ; Solomon SD; Sverdlov AL; Swarup V; van Veldhuisen DJ; Winkler S; Leon MB;
    Lancet; 2022 Mar; 399(10330):1130-1140. PubMed ID: 35120593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II).
    Berry N; Mauri L; Feldman T; Komtebedde J; van Veldhuisen DJ; Solomon SD; Massaro JM; Shah SJ
    Am Heart J; 2020 Aug; 226():222-231. PubMed ID: 32629295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction.
    Kaye DM; Hasenfuß G; Neuzil P; Post MC; Doughty R; Trochu JN; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Walton A; Muller D; Walters D; Hausleiter J; Raake P; Petrie MC; Bergmann M; Jondeau G; Feldman T; Veldhuisen DJ; Ponikowski P; Silvestry FE; Burkhoff D; Hayward C
    Circ Heart Fail; 2016 Dec; 9(12):e003662. PubMed ID: 27852653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP-HF II trial.
    Litwin SE; Komtebedde J; Seidler T; Borlaug BA; Winkler S; Solomon SD; Eicher JC; Mazimba S; Khawash R; Sverdlov AL; Hummel SL; Bugger H; Boenner F; Hoendermis E; Cikes M; Demers C; Silva G; van Empel V; Starling RC; Penicka M; Cutlip DE; Leon MB; Kitzman DW; van Veldhuisen DJ; Shah SJ;
    Eur J Heart Fail; 2024 Jan; 26(1):177-189. PubMed ID: 37989800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Device-based percutaneous treatments to decompress the left atrium in heart failure with preserved ejection fraction.
    Riccardi M; Tomasoni D; Vizzardi E; Metra M; Adamo M
    Heart Fail Rev; 2023 Mar; 28(2):315-330. PubMed ID: 36402928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure.
    Søndergaard L; Reddy V; Kaye D; Malek F; Walton A; Mates M; Franzen O; Neuzil P; Ihlemann N; Gustafsson F
    Eur J Heart Fail; 2014 Jul; 16(7):796-801. PubMed ID: 24961390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.